Glioma: all 1,425 studies
Page 2 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Image Quality and Safety of the MyVeo Surgical Visualization Headset During Standard Neurosurgical and Reconstructive Procedures Using Compatible Microscopes.Not yet recruitingNCT07164053
- Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)RecruitingNCT07159607
- Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade GliomaEnrolling by invitationNCT07126990Phase 1/2
- A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or OligodendrogliomaNot yet recruitingNCT07120984Phase 2
- Radiolabeled TSPO Targeted Molecular Probe in GliomaNot yet recruitingNCT07106008
- A Study for Cerebral Open Flow MicroperfusionNot yet recruitingNCT07089758Not applicable
- Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.RecruitingNCT07077616Early Phase 1
- Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care RadiationRecruitingNCT07076498Phase 1
- A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST TrialRecruitingNCT07074756Not applicable
- The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From BevacizumabRecruitingNCT07052877
- Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual DiseaseRecruitingNCT07025226Early Phase 1
- Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 MutationsRecruitingNCT07025018Phase 1
- Protoporphyrin Imaging in Multispectral Evaluation of ResectionsNot yet recruitingNCT07021573Not applicable
- FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF AlterationNot yet recruitingNCT07004075Phase 3
- Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival AnalysisEnrolling by invitationNCT06999148Phase 2
- DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET DysregulationsRecruitingNCT06988475Phase 2/3
- Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV GliomasRecruitingNCT06964737Phase 1
- IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)Not yet recruitingNCT06946680Phase 1
- Imaging of Solid Tumors Using 18F-TRXRecruitingNCT06942104Phase 1
- CUE-102 in Recurrent GlioblastomaRecruitingNCT06917885Phase 1
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent GlioblastomaRecruitingNCT06910306Not applicable
- Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain MetastasesRecruitingNCT06888817Phase 3
- Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical ApplicationRecruitingNCT06883214
- ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade GliomasRecruitingNCT06838676Phase 2
- Clinical Study of Carbon Ion Radiotherapy for High-grade GliomaRecruitingNCT06831773Not applicable
- Concurrent XRD-0394 With Radiation Therapy for High Grade GliomasRecruitingNCT06829173Early Phase 1
- A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/refractory Brain Gliomas with Positive CD70 ExpressionRecruitingNCT06828341Early Phase 1
- Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm TrialRecruitingNCT06818331Phase 2
- Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossRecruitingNCT06810544Phase 1/2
- Pharmacoscopy for Patients With Refractory Primary Brain TumorsRecruitingNCT06804655Phase 2
- Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent GliomaRecruitingNCT06801730Phase 2
- Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients With Brain Lesions.RecruitingNCT06797661Not applicable
- STRatifying Adult DIffuse Lower-grade Gliomas Based on Their VARIed Metabolic Profiles (STRADIVARI Project)RecruitingNCT06794736
- BC008-1A Injection for Recurrent CNS WHO G4 GliomaRecruitingNCT06773481Phase 1
- Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.Enrolling by invitationNCT06763965Phase 1/2
- Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the BrainRecruitingNCT06747728Not applicable
- Feasibility of Aspirate Tissue Monitoring in Neuro-oncological SurgeryRecruitingNCT06740097Not applicable
- Study of MT027 in Patients with Recurrent or Progressive High-grade GliomaNot yet recruitingNCT06737146Phase 1
- Surgical Suction Aspirates Fluorescence MeasurementRecruitingNCT06736470
- Craniospinal Irradiation in Histone AlteRed Midline GliomaRecruitingNCT06720727Not applicable
- MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric GliomasRecruitingNCT06712875Phase 1/2
- A Phase 2 Study of HX301 in Patients with High-grade GilomaRecruitingNCT06703255Phase 1/2
- Injection of Active Allogeneic Natural Killer Cells in Patients With GliomasRecruitingNCT06687681Phase 2
- FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for NeurosurgeryRecruitingNCT06684795Phase 2
- Chronic CED of TPT for Recurrent Malignant GliomaRecruitingNCT06666712Phase 1
- A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive GliomasRecruitingNCT06660056Phase 1
- Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain TumorsRecruitingNCT06650163Phase 1
- TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and MeningiomasRecruitingNCT06640582Phase 1/2
- Window of Opportunity Study of DSP-0390 in GliomasRecruitingNCT06636162Early Phase 1
- Atovaquone Combined With Radiation in Children With Malignant Brain TumorsRecruitingNCT06624371Phase 1
- Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas GliomasRecruitingNCT06620055
- Pilot IntraOperative Neuronal Electrophysiology in Tumor rElatEd suRgeryRecruitingNCT06617208Not applicable
- Monitoring of Patients With Low-grade Gliomas Using Circulating miRNARecruitingNCT06610851
- Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).RecruitingNCT06607692Phase 1/2
- Assessing Brain Metabolism Using MRS With Deuterated GlucoseRecruitingNCT06594315
- Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant GliomaRecruitingNCT06585527Phase 1
- Using the Epitranscriptome to Diagnose and Treat GliomasRecruitingNCT06575452Not applicable
- The Predictive Value of MRI for Adult-type Diffuse GliomasNot yet recruitingNCT06572592
- USPIO Enhanced MR Imaging in CNS Tumours (UMIC)RecruitingNCT06572475Not applicable
- Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma PatientsRecruitingNCT06546631
- Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS TumorsRecruitingNCT06528691Phase 2
- A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)RecruitingNCT06519682Not applicable
- Plasticizer Exposure and Its Consequences on HealthNot yet recruitingNCT06512298
- DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade GliomaRecruitingNCT06504381Phase 1/2
- Surgical Management of Low Grade GliomaNot yet recruitingNCT06499922
- In Vitro Models From Pediatric Brain TumorsNot yet recruitingNCT06499636
- A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsRecruitingNCT06496971Phase 3
- Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.RecruitingNCT06482905Phase 1
- Mapping of Electrical Properties in the BrainRecruitingNCT06470711
- Efficacy of a Mixed Distancial Neuropsychological Rehabilitation Program in Patients With Grade 2 or 3 Diffuse GliomaRecruitingNCT06468176Not applicable
- Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in GliomasRecruitingNCT06454097Not applicable
- STARLITE for Unresectable High-Grade GliomasRecruitingNCT06428045Phase 1
- Intraoperative Fluorescent Staining Combined With Microsurgery for GliomasNot yet recruitingNCT06417372
- 68Ga-NOTA-RM26 PET/CT in Glioma PatientsRecruitingNCT06412952Early Phase 1
- Glioma Intraoperative MicroElectroCorticoGraphyNot yet recruitingNCT06408428Not applicable
- PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies TrialRecruitingNCT06397560Not applicable
- Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant GliomaNot yet recruitingNCT06396481Early Phase 1
- Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of LifeRecruitingNCT06381726Not applicable
- Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade GliomasRecruitingNCT06381570Early Phase 1
- Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During SurgeryRecruitingNCT06363162Not applicable
- A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain TumorsRecruitingNCT06357377Phase 1
- Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related AggressivenessRecruitingNCT06348693
- Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent GlioblastomaRecruitingNCT06344130Phase 1
- Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionRecruitingNCT06333899Early Phase 1
- Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade GliomaRecruitingNCT06330337Phase 3
- A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsRecruitingNCT06326411Phase 1
- Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and GliomasNot yet recruitingNCT06323408
- CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young AdultsRecruitingNCT06305910Phase 1
- DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic AstrocytomaRecruitingNCT06264388Phase 2
- Niraparib and Temozolomide in Patients GlioblastomaNot yet recruitingNCT06258018Phase 1/2
- Ga-68 Prostate Specific Membrane Antigen PET/CT in GliomasNot yet recruitingNCT06241391Not applicable
- CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain GliomaRecruitingNCT06234319
- Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPGRecruitingNCT06221553Phase 1
- A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical TrialRecruitingNCT06215495Not applicable
- Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAsRecruitingNCT06203496
- Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRINot yet recruitingNCT06201351
- Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma PatientsRecruitingNCT06196918Not applicable
- Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 GliomasRecruitingNCT06180434
- Lerapolturev (PVSRIPO) in GBMRecruitingNCT06177964Phase 2
- FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade GliomaRecruitingNCT06172595Phase 2